Stay updated on SPRINTER Clinical Trial
Sign up to get notified when there's something new on the SPRINTER Clinical Trial page.

Latest updates to the SPRINTER Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a Phase III study on SNG001 for COVID-19 treatment, including eligibility criteria and study procedures. The only notable addition is a revision note indicating an update to version 2.15.0.SummaryDifference19%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to SPRINTER Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINTER Clinical Trial page.